Acta Scientific Pharmacology

Editorial Volume 1 Issue 10

SARS-CoV-2 Pandemic: Public Health Prevention Strategies

Gundu HR Rao*

Emeritus Professor, Laboratory Medicine and Pathology, Director, Thrombosis Research, Lillehei Heart Institute, University of Minnesota, USA

*Corresponding Author: Gundu HR Rao, Emeritus Professor, Laboratory Medicine and Pathology, Director, Thrombosis Research, Lillehei Heart Institute, University of Minnesota, USA.

Received: August 26, 2020; Published:September 01, 2020

×

  Public health strategies aimed at the primary prevention of infectious disease, starts with tracking of possible outbreaks, tracing the modes of transmission, seeking to prevent new cases of infection from occurring by interrupting the transmission of pathogens to susceptible hosts, increasing their resistance to infection. SARS-CoV-2, the most potent killer virus has caused unprecedented pandemic worldwide. At the time of this writing, according to the Johns Hopkins COVID-19 tracker (coronavirus.jhu.edu), global reported cases exceed 23.6 million, with over 800,000 deaths. In the most advanced country, the USA, there are 5.5 million infected individuals, and over 174,000 deaths. Brazil (3.4 mil) and India (2.8 mil) are ranked 2nd and 3rd in terms of number of infected individuals reported. In the absence of a cure, this pandemic has become a public health providers nightmare. Early preparation, messaging, and social distancing interventions during this first phase of the pandemic, have accomplished the goal of flattening the curve in some of the countries. In an unprecedented effort, hundreds of scientists, clinicians, public health workers as well as laymen worldwide, are in race against time, to answer myriad questions raised by individuals who are under a panic, to develop better diagnostic tools (preservatives, reactants and characterization technologies), novel drugs, interventions (pharmacological and nonpharmacological), vaccines and neutralizing antibodies [1-4].

×

Citation

Citation: Gundu HR Rao. “SARS-CoV-2 Pandemic: Public Health Prevention Strategies".Acta Scientific Pharmacology 1.10 (2020): 01-04.




Metrics

Acceptance rate36%
Acceptance to publication20-30 days

Indexed In


News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is September 30, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US